Myron Czuczman
CIK 1817716 · View on SEC EDGAR ↗
First SEC filing: Oct. 12, 2023 · Latest: Oct. 12, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CTOR | A | 825,000 | — | — | 825,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 19, 2025 | CTOR | A | 825,000 | — | — | 825,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 19, 2025 | CTOR | A | 825,000 | — | — | 825,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 12, 2024 | CTOR | A | 400,000 | — | — | 400,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 7, 2024 | CTXR | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 12, 2024 | CTOR | A | 1,400,000 | — | — | 1,400,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 12, 2024 | CTOR | A | 466,667 | — | — | 466,667 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 10, 2023 | CTXR | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 4, 2022 | CTXR | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 11, 2021 | CTXR | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-20) |
| July 14, 2020 | CTXR | A | 500,000 | — | — | 500,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 12, 2024 | CTOR | Stock Option (Right to Buy) | Common Stock (400,000) | $1.07 | Dec. 12, 2034 | 400,000 | Acquired |
| Nov. 7, 2024 | CTXR | Stock Option (Right to Purchase Common Stock) | Common Stock (300,000) | $0.38 | Nov. 7, 2034 | 300,000 | Acquired |
| Aug. 12, 2024 | CTOR | Stock Option (Right to Buy) | Common Stock (1,400,000) | $2.15 | July 5, 2033 | 1,400,000 | Acquired |
| Aug. 12, 2024 | CTOR | Stock Option (Right to Buy) | Common Stock (466,667) | $2.15 | July 5, 2033 | 466,667 | Acquired |
| Oct. 10, 2023 | CTXR | Stock Option (Right to Purchase Common Stock) | Common Stock (300,000) | $0.70 | Oct. 10, 2033 | 300,000 | Acquired |
| Oct. 4, 2022 | CTXR | Stock Option (Right to Purchase Common Stock) | Common Stock (300,000) | $1.25 | Oct. 4, 2032 | 300,000 | Acquired |
| Oct. 11, 2021 | CTXR | Stock Option (Right to Purchase Common Stock) | Common Stock (300,000) | $2.04 | Oct. 11, 2031 | 300,000 | Acquired |
| July 14, 2020 | CTXR | Stock Option (Right to Purchase Common Stock) ) | Common Stock (500,000) | $1.19 | July 14, 2030 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $450,000 | — | — | $410,220 | $157,500 | — | — | $2,461,470 |
| 2023 | $437,500 | — | — | $599,127 | $133,875 | — | — | $1,170,502 |
| 2021 | $400,000 | — | — | $174,857 | $148,750 | — | $917 | $724,524 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $225,000 | — | — | $770,000 | — | — | — | $995,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.